Timing of vaccination campaigns against pandemic influenza in a population dynamical model of Vancouver, Canada

Similar documents
Flu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Flu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Saskatchewan HIV Strategy: Social Network Approach

INFLUENZA Surveillance Report Influenza Season

Weekly Influenza News 2016/17 Season. Communicable Disease Surveillance Unit. Summary of Influenza Activity in Toronto for Week 43

Seasonality of influenza activity in Hong Kong and its association with meteorological variations

Review of Influenza Activity in San Diego County

18 Week 92% Open Pathway Recovery Plan and Backlog Clearance

A cumulative of 7,727 cases has been notified to date, since the onset of the epidemic on 25 October 2007.

Nova Scotia s Response to H1N1. Summary Report

City of Vancouver s Response to the Opioid Crisis Fire Chief Darrell Reid Vancouver Fire & Rescue Services (VF&RS)

Pakistan & Afghanistan: Will we soon see the end of polio?

What do epidemiologists expect with containment, mitigation, business-as-usual strategies for swine-origin human influenza A?

GREENWOOD PUBLIC SCHOOL DISTRICT PHYSICAL EDUCATION

Influenza Season, Boston

Global and National Trends in Vaccine Preventable Diseases. Dr Brenda Corcoran National Immunisation Office.

Experiences with pre-emptive cholera vaccination in emergency situations

Supplementary Online Content

THE SITUATION OF YELLOW FEVER IN THE AFRICAN REGION: THE PLAN TO END YF EPIDEMICS IN 2026

BIOST/STAT 578 A Statistical Methods in Infectious Diseases Lecture 16 February 26, Cholera: ecological determinants and vaccination

Hand, Foot, and Mouth Disease Situation Update. Hand, Foot, and Mouth Disease surveillance summary

Estimated epidemiologic parameters and morbidity associated with pandemic H1N1 influenza

H1N1 FEARS EXAGGERATED SAY MANY CANADIANS LIBS TEN PERCENTAGE POINTS BEHIND TORIES

California 2010 Pertussis Epidemic. Kathleen Winter, MPH Immunization Branch California Department of Public Health

Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005

Monthly measles and rubella monitoring report

Mathematical modeling of cholera

INFLUENZA EPIDEMIOLOGY IN KENYA

Alberta Health. Seasonal Influenza in Alberta Season. Analytics and Performance Reporting Branch

Essentials of Aggregate System Dynamics Infectious Disease Models

USAID s approach to the control of avian and pandemic influenza

INFLUENZA WATCH Los Angeles County

Durham Region Influenza Bulletin: 2017/18 Influenza Season

Empowering Weight Loss Charts & Logs Healthy Weight Chart Cholesterol Chart Blood Pressure Chart Exercise Calorie Burning Chart

Supplemental Analysis for Optimizing Tactics for use of the U.S. Antiviral Strategic National Stockpile for Pandemic (H1N1) Influenza, 2009

Middle East respiratory syndrome coronavirus (MERS-CoV) and Avian Influenza A (H7N9) update

Centennial Reflections on the 1918 Spanish Influenza Pandemic: Insights and Remaining Puzzles

Supplementary Material

Measles: United States, January 1 through June 10, 2011

Vibrio surveillance in the CIDT Era

Adult Immunizations. Business Health Care Group (BHCG) April 25, Cathy Edwards. Immunization Program Advisor

Outbreak Response/Epidemiology Influenza Weekly Report Arkansas

Sleep Market Panel. Results for June 2015

MHSC Program Evaluation Mental Health Service Corps. Dana Collins, Social Work Intern Jessica Neufeld, MPH Virna Little, PsyD, LCSW-r, MBA, CCM, SAP

Laboratory Evidence of Human Viral and Selected Non-viral Infections in Canada

8 Public Health Wales CDSC Weekly Influenza Surveillance Report Wednesday 21 August 2013 (covering week )

Influenza immunization timing

Outbreak Response/Epidemiology Influenza Weekly Report Arkansas

Malaria Incidence and Malaria Control Interventions among Under 5 s: Epidemic districts of Northern Uganda, July 2012-June 2015

Mathematical modelling of infectious disease transmission

Lumpy skin disease (LSD) Vaccination Data Collection

Progress in maternal and child health: Uzbekistan and WHO European Region

INFLUENZA IN MANITOBA 2010/2011 SEASON. Cases reported up to January 29, 2011

FMD Control Initiatives in Bangladesh

Dementia Content Report January Produced By The NHS Choices Reporting Team

Measles and rubella monitoring January 2015

Overview of the Radiation Exposure Doses of the Workers at Fukushima Daiichi Nuclear Power Station

Crisis Connections Crisis Line Phone Worker Training (Online/Onsite) Winter 2019

Chi-Square Goodness-of-Fit Test

Date : September Permit/License or Registration Application. Permit/License/ Notification/ Registration Description. Remark

Tri-County Opioid Safety Coalition Data Brief December 2017 Clackamas, Multnomah, and Washington Counties

Thailand s avian influenza control and pandemic influenza preparedness. Supamit Chunsuttiwat Ministry of Public Health 12 July 2006

Assessing Change with IIS. Steve Robison Oregon Immunization Program

Heroin & Fentanyl Related Deaths in Cuyahoga County

Alberta Health. Seasonal Influenza in Alberta. 2016/2017 Season. Analytics and Performance Reporting Branch

Predicting the Path of Infectious Diseases

Published by the Pharmaceutical Services Division to provide information for British Columbia s health care providers

PERTUSSIS REPORT. November 2013

The Spanish flu in Denmark 1918: three contrasting approaches

Blood supply and blood products: Regulatory issues in the pandemic context

Use of epidemic models in planning pandemic mitigation

U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs

Analysis of Meter Reading Validation Tolerances proposed by Project Nexus

Measurement and Descriptive Statistics. Katie Rommel-Esham Education 604

LABORATORY TRENDS. Laboratory News PUBLIC HEALTH MICROBIOLOGY & REFERENCE LABORATORY. Vancouver, BC. January 20, 2012.

Influenza 2009: Not Yet The Perfect Storm

SUPPLEMENTARY APPENDICES FOR ONLINE PUBLICATION. Supplement to: All-Cause Mortality Reductions from. Measles Catch-Up Campaigns in Africa

An Updated Approach to Colon Cancer Screening and Prevention

Egypt Success Story In Combating Avian Influenza

Global Health Security: Preparedness and Response: can we do better and stay safe?

Past Influenza Pandemics

County of San Diego HEALTH AND HUMAN SERVICES AGENCY

Confounding in influenza VE studies in seniors, and possible solutions

How to Detect and Confirm Epidemic Meningococcal Disease

In accordance with 902 KAR 2:020, cases of acute hepatitis A should be reported within 24 hours.

Detailed Parameters of the BARDA Interactive Flu Model

Characterising hepatitis C virus transmission dynamics in a highrisk incarcerated population

ARIZONA INFLUENZA SUMMARY Week 1 (1/4/2015 1/10/2015)

To view past issues, go to: The New 13-Valent Pneumococcal Conjugate Vaccine (PCV13)

California Immunization Coalition 2018 Summit Karen Smith, MD, MPH, Director California Department of Public Health

Mathematical Modelling of Infectious Diseases. Raina MacIntyre

Complete Central Registry Treatment Information Requires Ongoing Reporting and Consolidation Well Beyond 6-Month Reporting

Kansas EMS Naloxone (Narcan) Administration

in collaboration with NTP & PTP Saira Khowaja Indus Hospital ldr TB Control lprogram

Workbook Method for estimating HIV prevalence in low level or concentrated epidemics

Research Article Epidemiological Patterns of Varicella in the Period of 1977 to 2012 in the Rijeka District, Croatia

Malaria Vaccine Implementation Programme (MVIP) update and framework for policy decision. Mary J Hamel, WHO MPAC, 11 April 2018

Cancer Immunotherapy Pilot Program/ Patents 4 Patients. USPTO BCP Customer Partnership Meeting Alexandria, VA August 2, 2017

Situation. There are so many deserving causes that need support to continue their amazing work, and in 2018 they re all competing.

Transcription:

Timing of vaccination campaigns against pandemic influenza in a population dynamical model of Vancouver, Canada Jessica M. Conway 1,2, Rafael Meza 2, Bahman Davoudi-Dehagi 2, Ashleigh Tuite 3, Babak Pourbohloul 2, and the CanPan Team 1 Department of Mathematics University of British Columbia 2 Division of Mathematical Modeling University of British Columbia Centre for Disease Control 3 Dalla Lana School of Public Health University of Toronto January 11, 211 Conway et al. (UBC) Campaign Timing in Vancouver, CAN 11 Jan 211 1 / 19

Introduction - ph1n1 influenza In BC: First cases in April/May 29... but epidemic began in earnest at the start of September. 18 hospitalizations / 57 deaths in BC. Characterized by higher attack rates in younger individuals. BC ph1n1 Surveillance Update, Feb 25 21. Conway et al. (UBC) Campaign Timing in Vancouver, CAN 11 Jan 211 2 / 19

Introduction - Immunization BC ph1n1 vaccination campaign began Oct. 26th, 29. Goal: Model pandemic influenza in an urban setting (we use GVRD as representative). Examine role of vaccination campaign timing and targeting strategies in mitigating impact of pandemic. Conway et al. (UBC) Campaign Timing in Vancouver, CAN 11 Jan 211 3 / 19

Simplified Model Schematic Complicating details: Split exposed, infectious compartments so distribution of time spent in them is a more realistic gamma. Heterogeneous model: each compartment represents a combination of different age and activity levels... Conway et al. (UBC) Campaign Timing in Vancouver, CAN 11 Jan 211 4 / 19

Age and activity levels Age Address different vulnerability to infection, mortality rates, etc and assess different vaccination coverage strategies. Activity Capture contribution of individuals with very high contact rates. Population fraction (%) 4 35 3 25 2 15 1 5 5 6 15 16 3 31 1 1+ Pourbohloul et al. (25) 2 2 4 5 17 18 2425 5455 64 65+65+(care) Age groups Note: We focus on GVRD as a representative urban area. Results shown for broader age groups (to compare with data). Conway et al. (UBC) Campaign Timing in Vancouver, CAN 11 Jan 211 5 / 19

Simplified Model Schematic Each compartment represents 4 sub-compartments (8 age groups 5 activity levels). Further key detail (before you ask!): Carefully derive contact probabilities for transmissibility from Vancouver contact network e.g. probability that someone age 25-54 with low activity level contacts someone age 5-17 with high activity levels, etc. Conway et al. (UBC) Campaign Timing in Vancouver, CAN 11 Jan 211 6 / 19

Baseline Parameters Variable Value Latent period (mean) 3 days Initial asymptomatic infectious period (mean) 1 day Total duration of infectiousness (mean) 7 days Basic reproduction number R 1.4 Vaccine Efficacy.9 Proportion of pop. with pre-existing immunity.5 (age 55+ only) Conway et al. (UBC) Campaign Timing in Vancouver, CAN 11 Jan 211 7 / 19

Vaccination Coverages Consider 3 vaccination coverage strategies: strategy coverages in GVRD. UC strategy Uniform coverage across all age groups PC strategy Immunizing school-aged children & their parents only Note: overall coverage 45% for /UC, 36% for PC. Age specific coverage (%) 1 9 8 7 6 5 4 3 2 1 UC PC 2 2 4 5 17 18 24 25 54 55 64 65+ 65+ (care) Age Group Conway et al. (UBC) Campaign Timing in Vancouver, CAN 11 Jan 211 8 / 19

Model predictions - Vancouver ph1n1 epidemic Age Spec. Inc. per 1, 2 15 1 5 Age Groups 4 5 17 18 54 55+ Oct 1 Nov 1 Dec 1 Jan 1 Feb 1 Mar 1 ICs: 1 cases on Sept 6 (educated guess, based on 1 confirmed cases). 8-week vaccination campaign starting October 26th, 21. Conway et al. (UBC) Campaign Timing in Vancouver, CAN 11 Jan 211 9 / 19

Vaccination rates Vaccinations concurrent with epidemic What kind of distribution rates should we consider? Conway et al. (UBC) Campaign Timing in Vancouver, CAN 11 Jan 211 1 / 19

Model predictions - Vancouver ph1n1 epidemic Age Spec. Inc. per 1, 2 15 1 5 Age Groups 4 5 17 18 54 55+ Oct 1 Nov 1 Dec 1 Jan 1 Feb 1 Mar 1 ICs: 1 cases on Sept 6 (educated guess, based on 1 confirmed cases). 8-week vaccination campaign starting October 26th, 21. Conway et al. (UBC) Campaign Timing in Vancouver, CAN 11 Jan 211 11 / 19

Model predictions - Vancouver ph1n1 epidemic A B September October Fraction of total cases C.5.4.3.2.1 Reported Model 4 5 17 18 54 55+ Age groups November Fraction of total cases.5.4.3.2.1 4 5 17 18 54 55+ Age groups D Cumulative cases Sept.1 to Dec.1 Fraction of total cases.5.4.3.2.1 Fraction of total cases.5.4.3.2.1 4 5 17 18 54 55+ Age groups 4 5 17 18 54 55+ Age groups Conway et al. (UBC) Campaign Timing in Vancouver, CAN 11 Jan 211 12 / 19

Model predictions - Vancouver ph1n1 epidemic Age Spec. Inc. per 1, 2 15 1 5 Age Groups 4 5 17 18 54 55+ Oct 1 Nov 1 Dec 1 Jan 1 Feb 1 Mar 1 ICs: 1 cases on Sept 6 (educated guess, based on 1 confirmed cases). 8-week vaccination campaign starting October 26th, 21. Conway et al. (UBC) Campaign Timing in Vancouver, CAN 11 Jan 211 13 / 19

Different Campaign Start Dates % reduction in final attack rate 8 6 4 2 Campaign Length 12 wks 1 wks 8 wks 6 wks 4 wks Jul Aug Sept Oct Nov Dec Start date of vaccination campaign Conway et al. (UBC) Campaign Timing in Vancouver, CAN 11 Jan 211 14 / 19

Different coverage strategies - attack rate % reduction in final attack rate 8 6 4 Start of epidemic Targeting strategy campaign start date 2 Parents & children Uniform Jul Aug Sept Oct Nov Dec Start date of vaccination campaign Conway et al. (UBC) Campaign Timing in Vancouver, CAN 11 Jan 211 15 / 19

Different coverage strategies - mortality % reduction in mortality 8 6 4 Start of epidemic Targeting strategy campaign start date 2 Parents & children Uniform Jul Aug Sept Oct Nov Dec Start date of vaccination campaign Conway et al. (UBC) Campaign Timing in Vancouver, CAN 11 Jan 211 16 / 19

Different coverage strategies Attack Rate: Mortality: % reduction in final attack rate 8 6 4 Start of epidemic Targeting strategy campaign start date 2 Parents & children Uniform Jul Aug Sept Oct Nov Dec Start date of vaccination campaign % reduction in mortality 8 6 4 Start of epidemic Targeting strategy campaign start date 2 Parents & children Uniform Jul Aug Sept Oct Nov Dec Start date of vaccination campaign Notice: Better strategy depends on goals. As campaign is increasingly delayed, strategy becomes less important. Conway et al. (UBC) Campaign Timing in Vancouver, CAN 11 Jan 211 17 / 19

Vaccine Efficacy ( strategy) Vaccine Efficacy 1.9.8.7.6 Start.9of epidemic.85.75.65.55.25.15 start date of vaccination campaign.5.45.35.5 Jul Aug Sept Oct Nov Dec Start date of vaccination campaign Impact of efficacy diminished as epidemic progresses. A lesser vaccine distributed early is preferable. Conway et al. (UBC) Campaign Timing in Vancouver, CAN 11 Jan 211 18 / 19

Discussion Developed a model of pandemic influenza in an urban setting that I I captures variability in age and behaviour includes vaccinations concurrent with epidemic validating it through comparison with ph1n1 influenza in GVRD. Different campaign start times: the sooner the better. Different coverage strategies: effective for campaigns started before/early in epidemic, less so for campaigns started later. Are the logistics worth the cost? Conway et al. (UBC) Campaign Timing in Vancouver, CAN 11 Jan 211 19 / 19

Role of mortality parameters Consider different mortality profiles: log 1 (Mortality per 1, pop.) 3 2.5 2 1.5 1.5 Source of mortality parameters Donaldson et al. (21) Hadler et al. (21), method 1 Hadler et al. (21), method 2 Tuite et al. (21) 2 2 4 5 17 18 24 25 54 55 64 65+ 65+, care Age Groups Conway et al. (UBC) Campaign Timing in Vancouver, CAN 11 Jan 211 2 / 19

Role of mortality parameters Resulting mortality reductions: % reduction in mortality 8 6 4 Targeting strategy campaign start date 2 Parents & children Uniform Jul Aug Sept Oct Nov Dec Start date of vaccination campaign % reduction in mortality 8 6 4 Targeting strategy campaign start date 2 Parents & children Uniform Jul Aug Sept Oct Nov Dec Start date of vaccination campaign % reduction in mortality 8 6 4 Targeting strategy campaign start date 2 Parents & children Uniform Jul Aug Sept Oct Nov Dec Start date of vaccination campaign % reduction in mortality 8 6 4 Targeting strategy campaign start date 2 Parents & children Uniform Jul Aug Sept Oct Nov Dec Start date of vaccination campaign Conway et al. (UBC) Campaign Timing in Vancouver, CAN 11 Jan 211 21 / 19

Time course of Vancouver epidemic Model prediction: Incident cases per 1 population 5 45 4 35 3 25 2 15 1 5 4 5 17 18 54 55+ Sept 1 Oct 1 Nov 1 Dec 1 Jan 1 Feb 1 Conway et al. (UBC) Campaign Timing in Vancouver, CAN 11 Jan 211 22 / 19

Sensitivity Analysis Vary latent period (2-4 days) and infectious period (5-7 days). Cumulative Attack Rate (%) 6 5 4 3 R =1.8 R 2 =1.6 Start of R 1 =1.4 vaccination R =1.2 campaign Sept Oct Nov Dec Jan Feb Mar Apr May Date Conway et al. (UBC) Campaign Timing in Vancouver, CAN 11 Jan 211 23 / 19